Predictive value of pretreatment peripheral blood N/CD4 and N/CD8 ratios for the efficacy of radiotherapy for esophageal cancer

This study aimed to explore the predictive value of pretreatment peripheral blood immune cell subsets in analyzing the outcomes of patients who underwent radiation therapy for esophageal cancer at their first visit.

Saved in:
Bibliographic Details
Main Authors: Jiang Yu-Rong, Su Yu-Ting, Hu Jing, Ding Yan, Wang Lu, Wang Zi-Yu, Sheng Wan-Ying, Fan Yi-Xu, Chu Liang-Mei, Yang Yu-Fei, Wen Yi, Han Miao, Zhou Si-Yuan, Dai Chun-Hua, Wang Xu
Format: Article
Language:English
Published: Sciendo 2025-03-01
Series:Radiology and Oncology
Subjects:
Online Access:https://doi.org/10.2478/raon-2025-0015
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849737231006171136
author Jiang Yu-Rong
Su Yu-Ting
Hu Jing
Ding Yan
Wang Lu
Wang Zi-Yu
Sheng Wan-Ying
Fan Yi-Xu
Chu Liang-Mei
Yang Yu-Fei
Wen Yi
Han Miao
Zhou Si-Yuan
Dai Chun-Hua
Wang Xu
author_facet Jiang Yu-Rong
Su Yu-Ting
Hu Jing
Ding Yan
Wang Lu
Wang Zi-Yu
Sheng Wan-Ying
Fan Yi-Xu
Chu Liang-Mei
Yang Yu-Fei
Wen Yi
Han Miao
Zhou Si-Yuan
Dai Chun-Hua
Wang Xu
author_sort Jiang Yu-Rong
collection DOAJ
description This study aimed to explore the predictive value of pretreatment peripheral blood immune cell subsets in analyzing the outcomes of patients who underwent radiation therapy for esophageal cancer at their first visit.
format Article
id doaj-art-e7348d2eca424c7cb4a57149986481ab
institution DOAJ
issn 1581-3207
language English
publishDate 2025-03-01
publisher Sciendo
record_format Article
series Radiology and Oncology
spelling doaj-art-e7348d2eca424c7cb4a57149986481ab2025-08-20T03:07:00ZengSciendoRadiology and Oncology1581-32072025-03-0159225726610.2478/raon-2025-0015Predictive value of pretreatment peripheral blood N/CD4 and N/CD8 ratios for the efficacy of radiotherapy for esophageal cancerJiang Yu-Rong0Su Yu-Ting1Hu Jing2Ding Yan3Wang Lu4Wang Zi-Yu5Sheng Wan-Ying6Fan Yi-Xu7Chu Liang-Mei8Yang Yu-Fei9Wen Yi10Han Miao11Zhou Si-Yuan12Dai Chun-Hua13Wang Xu141Department of Thoracic Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China2Department of Abdominal Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China1Department of Thoracic Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China3Department of Head and Neck and Comprehensive Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China2Department of Abdominal Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China1Department of Thoracic Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China1Department of Thoracic Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China1Department of Thoracic Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China1Department of Thoracic Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China3Department of Head and Neck and Comprehensive Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China1Department of Thoracic Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China3Department of Head and Neck and Comprehensive Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China1Department of Thoracic Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China1Department of Thoracic Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. China1Department of Thoracic Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P. R. ChinaThis study aimed to explore the predictive value of pretreatment peripheral blood immune cell subsets in analyzing the outcomes of patients who underwent radiation therapy for esophageal cancer at their first visit.https://doi.org/10.2478/raon-2025-0015peripheral blood n/cd4 and n/cd8esophageal cancerradiotherapyefficacy prediction
spellingShingle Jiang Yu-Rong
Su Yu-Ting
Hu Jing
Ding Yan
Wang Lu
Wang Zi-Yu
Sheng Wan-Ying
Fan Yi-Xu
Chu Liang-Mei
Yang Yu-Fei
Wen Yi
Han Miao
Zhou Si-Yuan
Dai Chun-Hua
Wang Xu
Predictive value of pretreatment peripheral blood N/CD4 and N/CD8 ratios for the efficacy of radiotherapy for esophageal cancer
Radiology and Oncology
peripheral blood n/cd4 and n/cd8
esophageal cancer
radiotherapy
efficacy prediction
title Predictive value of pretreatment peripheral blood N/CD4 and N/CD8 ratios for the efficacy of radiotherapy for esophageal cancer
title_full Predictive value of pretreatment peripheral blood N/CD4 and N/CD8 ratios for the efficacy of radiotherapy for esophageal cancer
title_fullStr Predictive value of pretreatment peripheral blood N/CD4 and N/CD8 ratios for the efficacy of radiotherapy for esophageal cancer
title_full_unstemmed Predictive value of pretreatment peripheral blood N/CD4 and N/CD8 ratios for the efficacy of radiotherapy for esophageal cancer
title_short Predictive value of pretreatment peripheral blood N/CD4 and N/CD8 ratios for the efficacy of radiotherapy for esophageal cancer
title_sort predictive value of pretreatment peripheral blood n cd4 and n cd8 ratios for the efficacy of radiotherapy for esophageal cancer
topic peripheral blood n/cd4 and n/cd8
esophageal cancer
radiotherapy
efficacy prediction
url https://doi.org/10.2478/raon-2025-0015
work_keys_str_mv AT jiangyurong predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT suyuting predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT hujing predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT dingyan predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT wanglu predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT wangziyu predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT shengwanying predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT fanyixu predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT chuliangmei predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT yangyufei predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT wenyi predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT hanmiao predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT zhousiyuan predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT daichunhua predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer
AT wangxu predictivevalueofpretreatmentperipheralbloodncd4andncd8ratiosfortheefficacyofradiotherapyforesophagealcancer